Up-regulated miR155 reverses the epithelial-mesenchymal transition induced by EGF and increases chemo-sensitivity to cisplatin in human Caski cervical cancer cells - Wikidata - wikimedia - TriplyDB

Up-regulated miR155 reverses the epithelial-mesenchymal transition induced by EGF and increases chemo-sensitivity to cisplatin in human Caski cervical cancer cells

Up-regulated miR155 reverses the epithelial-mesenchymal transition induced by EGF and increases chemo-sensitivity to cisplatin in human Caski cervical cancer cells

http://www.wikidata.org/entity/Q34533633

about

Molecular mechanisms of cisplatin resistance in cervical cancer EMT-Inducing Molecular Factors in Gynecological Cancers Multistep model of cervical cancer: participation of miRNAs and coding genes MicroRNA in cervical cancer: OncomiRs and tumor suppressor miRs in diagnosis and treatment Deregulated miRNAs in human cervical cancer: functional importance and potential clinical use.A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer.A role for microRNA-155 expression in microenvironment associated to HPV-induced carcinogenesis in K14-HPV16 transgenic mice.Knockdown of ST6Gal-I increases cisplatin sensitivity in cervical cancer cells.Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).Role of Annexin A2 in the EGF-induced epithelial-mesenchymal transition in human CaSki cells.Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions.Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.Array analysis for potential biomarker of gemcitabine identification in non-small cell lung cancer cell lines.MicroRNAs in gynecological cancers: Small molecules with big implications.MicroRNA-206 is differentially expressed in Brca1-deficient mice and regulates epithelial and stromal cell compartments of the mouse mammary gland MiR-214 inhibits cell migration, invasion and promotes the drug sensitivity in human cervical cancer by targeting FOXM1 Integrated Analysis of Dysregulated miRNA-gene Expression in HMGA2-silenced Retinoblastoma Cells miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal Cancer

P2860

Q26746228-84B893B6-5044-4533-8BD6-3064C20F0A60 Q26781912-1B673D18-2FB3-4479-9A04-86492F4E6A49 Q27001000-D5918BB2-C32D-4474-BA30-47848E7328E6 Q27011808-B64AEB29-8D52-4458-AF48-82E0924AF642 Q30241934-C617271B-81C6-417C-88C5-46EC9552D8B0 Q34049716-7C189087-361D-4DE8-B89E-EAD2E988B7F0 Q35019191-8F47CF26-CD4F-4628-AD85-3E66C96EB2C8 Q36226902-3609BC52-0011-46BF-A02D-1899EA7C36B4 Q36992190-546AFBCE-56BC-47CB-BD9A-74CF30671370 Q37594006-6E6EF8F3-097D-425C-BC20-3E79FD2ABD32 Q37681322-2E142966-4B7A-44FF-B62D-CE5DC415F86E Q38258014-CB49A680-438A-4D00-A036-E20BAFBEE6AF Q39095223-0AC58C97-6B35-4D39-B9E2-639BF866852B Q39333266-49BB9E11-8AA5-4BA2-BE5C-F9D06E66057A Q40747141-02568730-A211-42C1-BD2C-DA51BCA9EF04 Q41549238-C50853EA-2511-4D38-B667-B3C67E4E9FEB Q42094013-9819FC7E-95A9-4634-B4F1-D4C0185F21CA Q58799032-4840F52B-3581-4D70-B4F1-D6F0A74EEFFE

P2860

Up-regulated miR155 reverses the epithelial-mesenchymal transition induced by EGF and increases chemo-sensitivity to cisplatin in human Caski cervical cancer cells

http://www.wikidata.org/entity/Q34533633

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Up-regulated miR155 reverses t ...... an Caski cervical cancer cells

@ast

Up-regulated miR155 reverses t ...... an Caski cervical cancer cells

@en

Up-regulated miR155 reverses t ...... an Caski cervical cancer cells

@nl

type

label

Up-regulated miR155 reverses t ...... an Caski cervical cancer cells

@ast

Up-regulated miR155 reverses t ...... an Caski cervical cancer cells

@en

Up-regulated miR155 reverses t ...... an Caski cervical cancer cells

@nl

prefLabel

Up-regulated miR155 reverses t ...... an Caski cervical cancer cells

@ast

Up-regulated miR155 reverses t ...... an Caski cervical cancer cells

@en

Up-regulated miR155 reverses t ...... an Caski cervical cancer cells

@nl

P1433

Q34533633-3A0F31B2-0B90-4C98-9FAF-F2DA20412865

P1476

Q34533633-A4CEDC4B-8543-4593-9176-20035DD27C6A

P2093

Q34533633-1E36FCDA-5E4D-4F18-B810-E1B63425414C

Q34533633-871B368B-1A87-433C-B600-3E6E5380575A

Q34533633-8CB3DFE3-8637-412F-83D3-17E23ECEC4D8

Q34533633-93FE0056-8172-4D07-9CD9-68393F8C951F

Q34533633-9C97DC3A-F44E-4A94-9623-E7C9800B9681

Q34533633-9EC83235-C499-4AF7-A4A8-8BF38BA9252C

Q34533633-F17DF228-97D7-496C-8EB9-8C861612BC63

P2860

Q34533633-03113769-D062-42F1-8DCE-27F6CA72C9FD

Q34533633-03D70C0A-5E10-43E4-8E94-E1F70AD41F1A

Q34533633-08AEA890-AE55-4ED5-B2D5-64BDC006A960

Q34533633-1A74045A-FFB8-4977-8B3D-7407D6FD5A92

Q34533633-1CA8F0E2-544E-43F3-A006-E15476C8AA71

Q34533633-2C604619-7377-431C-A366-D2A35C46024E

Q34533633-2D195C9E-6F59-4CC0-AFBB-7CBCFDEA7884

Q34533633-330FC362-196E-4DDB-9455-24C89EC003CF

Q34533633-3A2D6E40-3048-499B-8C9A-3B263F1F16B6

Q34533633-429DEF9B-AE92-4738-9C5D-B0EC42B50106

P304

Q34533633-35F8BC80-A07A-42E1-8A4A-53F305F4B04A

P31

Q34533633-B1EED4E3-17B3-4597-98EA-4F83732535AF

P356

Q34533633-14ED0460-1C49-4784-A0FE-D7F10EDB3A37

P407

Q34533633-10CEEAA3-E13A-49A0-B3DB-7DD9639C0380

P433

Q34533633-43B6298D-2B33-4838-90AB-504A5098B9A0

P478

Q34533633-59312987-DC12-4F82-9BBF-8311E186C0D4

P577

Q34533633-F431B59D-D251-4F8C-B352-8423D0E6FFC4

P5875

Q34533633-F96B97ED-4A9C-4E29-83CB-29DD58DD3B47

P698

Q34533633-10FD0124-F9A3-4CA1-9BF1-95C7098880CF

P932

Q34533633-11B3BBCF-82AE-4091-A1A2-0B8AFB5ACD17

P356

JOURNAL.PONE.0052310

P1433

P1476

Up-regulated miR155 reverses t ...... an Caski cervical cancer cells

@en

P2093

Cui Lei

http://www.w3.org/2001/XMLSchema#string

Han Yu

http://www.w3.org/2001/XMLSchema#string

Liming Huang

http://www.w3.org/2001/XMLSchema#string

Liting Wu

http://www.w3.org/2001/XMLSchema#string

Yanlin Wang

http://www.w3.org/2001/XMLSchema#string

Yiling Huang

http://www.w3.org/2001/XMLSchema#string

Yurong Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma

MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA

Molecular profiling of cervical cancer progression

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development

EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target.

Epithelial-mesenchymal transitions in development and disease

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer

A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition

Cyclin D1, Id1 and EMT in breast cancer.

P304

e52310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0052310

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234043819

http://www.w3.org/2001/XMLSchema#string

P698

23284982

http://www.w3.org/2001/XMLSchema#string

P932

3527539

http://www.w3.org/2001/XMLSchema#string